Heloísa Lizotti Cilião

Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer

Marilesia Ferreira de Souza, Hellen Kuasne, Mateus Camargo Barros‐Filho et al. · PLoS ONE · 2017 · 107 citations · Full text

Medicine, Molecular Biology, Oncology +17

LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds

Ana Flávia Leal Specian, Juliana Mara Serpeloni, Katiuska Tuttis et al. · Cytotechnology · 2016 · 43 citations · Full text

Life Sciences, Biochemistry, Drug Discovery +5

Circulating mRNA signature as a marker for high-risk prostate cancer

Marilesia Ferreira de Souza, Hellen Kuasne, Mateus Camargo Barros‐Filho et al. · Carcinogenesis · 2019 · 28 citations · Full text

Medicine, Oncology, Urology +17

Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells

Heloísa Lizotti Cilião, Diego Luís Ribeiro, Rossana Batista Oliveira Camargo-Godoy et al. · Experimental and Toxicologic Pathology · 2014 · 26 citations

Medicine, Pharmacology, Toxicology +10

Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer

Monyse de Nóbrega, Heloísa Lizotti Cilião, Marilesia Ferreira de Souza et al. · Genetics and Molecular Biology · 2020 · 18 citations · Full text

Medicine, Genetics, Molecular Genetics +17